• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    More On ONCY

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials


    Oncolytics Biotech Inc. (ONCY)

    -NasdaqCM
    0.55 Up 0.04(6.90%) Dec 19, 3:59PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:3.79
    Median Target:3.25
    High Target:8.00
    Low Target:1.72
    No. of Brokers:6

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Sep 17, 2014StifelDowngradeBuyHold
    Aug 30, 2012Stifel NicolausInitiated Buy
    May 17, 2011OppenheimerInitiated Perform
    Apr 13, 2011WedbushInitiated Outperform
    Dec 22, 2009Rodman & RenshawDowngradeMkt OutperformMkt Perform
    Oct 16, 2008Merriman Curhan FordInitiated Buy
    Jan 15, 2008Rodman & RenshawInitiated Mkt Outperform
    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0222
    Buy0221
    Hold0221
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.